The combination of air pollution, dense urban development and limited green spaces increases the risk of asthma in both children and adults.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

A global partnership agreement with Eckuity Capital to develop next-generation technology infrastructure-built on strong ...

Late-breaking findings on pulmonology, critical care, and sleep medicine will be presented at the American Thoracic Society ...

A study led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by "la Caixa" Foundation, in collaboration with the Clínic-IDIBAPS, has shown for the first time, how lung ...

Scientists at the Barcelona Institute for Global Health (ISGlobal) led the study, published Thursday in The Lancet ...

A study led by the Barcelona Institute for Global Health (ISGlobal) in collaboration with the Clínic-IDIBAPS, has shown, for ...

The Health Sciences Authority (HSA) has approved Dupixent (dupilumab) for adults as an add-on maintenance treatment for uncontrolled chronic obstructive pulmonary disease (COPD) characterized by ...

The global COPD therapeutics market is on a robust growth trajectory, having achieved a market valuation of USD 12,144.1 million in 2023, and is projected to reach USD 20,035.5 million by 2033, ...

Request To Download Free Sample of This Strategic Report@ COPD and asthma devices are crucial in the management and treatment of respiratory diseases, providing relief and improving the quality of ...

Analyses support Ohtuvayre® (ensifentrine) as a first-in-class selective dualinhibitor of PDE3 and PDE4 for a broad COPD ...

The global breath analyzer market Key growth drivers include stringent drunk-driving regulations, technological advancements, and increasing adoption ...